JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
China flag China · Delayed Price · Currency is CNY
27.09
-0.11 (-0.40%)
At close: Jan 22, 2026

SHA:603235 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Operating Revenue
2,1982,1811,8512,2532,4662,265
Upgrade
Other Revenue
282830.651.7155.9738.74
Upgrade
2,2262,2091,8822,3052,5222,304
Upgrade
Revenue Growth (YoY)
10.84%17.35%-18.34%-8.63%9.50%13.76%
Upgrade
Cost of Revenue
1,2481,2881,1741,4501,4321,054
Upgrade
Gross Profit
978.41920.91708.11854.671,0901,250
Upgrade
Selling, General & Admin
203.86177.02169.21174.88140.19130.02
Upgrade
Research & Development
102.43103.82111.9689.4658.9449.36
Upgrade
Other Operating Expenses
25.617.8619.8121.9722.7723.43
Upgrade
Operating Expenses
330.29301.92299.32282.46228.3201.83
Upgrade
Operating Income
648.13619408.79572.21862.111,048
Upgrade
Interest Expense
-5.17-2.48-2.1-6.93-12.67-13.06
Upgrade
Interest & Investment Income
43.2964.8176.5422.884.3413.2
Upgrade
Currency Exchange Gain (Loss)
54.1954.1931.2482.37-26.95-78.04
Upgrade
Other Non Operating Income (Expenses)
-29.58-1.250.32-1.74-1.61-0.94
Upgrade
EBT Excluding Unusual Items
710.86734.26514.79668.79825.22969.17
Upgrade
Gain (Loss) on Sale of Investments
2.72.24-4.33-6.61-
Upgrade
Gain (Loss) on Sale of Assets
-2.07-1.07-0.09-1.07-2.140.05
Upgrade
Asset Writedown
-9.38-0.61-0.19-0.86--3.29
Upgrade
Other Unusual Items
36.3236.9550.6654.5756.9180.8
Upgrade
Pretax Income
738.43771.77565.17725.76873.371,047
Upgrade
Income Tax Expense
121.39120.5589.32103.64129.49159.64
Upgrade
Net Income
617.04651.22475.85622.12743.89887.09
Upgrade
Net Income to Common
617.04651.22475.85622.12743.89887.09
Upgrade
Net Income Growth
10.69%36.85%-23.51%-16.37%-16.14%21.90%
Upgrade
Shares Outstanding (Basic)
435437437412394394
Upgrade
Shares Outstanding (Diluted)
435437437412394394
Upgrade
Shares Change (YoY)
-0.18%0.11%5.96%4.68%-0.10%-
Upgrade
EPS (Basic)
1.421.491.091.511.892.25
Upgrade
EPS (Diluted)
1.421.491.091.511.892.25
Upgrade
EPS Growth
10.89%36.70%-27.82%-20.11%-16.00%21.82%
Upgrade
Free Cash Flow
-235.15-567.3193.61346.11603.13860.63
Upgrade
Free Cash Flow Per Share
-0.54-1.300.440.841.532.18
Upgrade
Dividend Per Share
0.6800.6800.5000.710--
Upgrade
Dividend Growth
36.00%36.00%-29.58%---
Upgrade
Gross Margin
43.95%41.70%37.63%37.08%43.23%54.26%
Upgrade
Operating Margin
29.12%28.03%21.72%24.83%34.18%45.50%
Upgrade
Profit Margin
27.72%29.49%25.29%26.99%29.49%38.51%
Upgrade
Free Cash Flow Margin
-10.56%-25.69%10.29%15.02%23.91%37.36%
Upgrade
EBITDA
810.53770.02544.64695.81969.571,137
Upgrade
EBITDA Margin
36.41%34.87%28.94%30.19%38.44%49.37%
Upgrade
D&A For EBITDA
162.4151.02135.85123.6107.4689.33
Upgrade
EBIT
648.13619408.79572.21862.111,048
Upgrade
EBIT Margin
29.12%28.03%21.72%24.83%34.18%45.50%
Upgrade
Effective Tax Rate
16.44%15.62%15.80%14.28%14.83%15.25%
Upgrade
Revenue as Reported
2,2262,2091,8822,3052,522-
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.